| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jul 24 | MCK McKesson | RSU Common Stock | Grant | Acquire A | No | No | 0 | 349 | 0.00 | 349 |
| 18 Jun 24 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 5,345 | 0.00 | 25,075 |
| 18 Jun 24 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 37.42 | 9,900 | 370.46 k | 9,900 |
| 5 Jun 24 | SYRS Syros Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 4,000 |
| 5 Jun 24 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 5.3 | 6,000 | 31.80 k | 6,000 |
| 3 Jun 24 | MCK McKesson | RSU Common Stock | Grant | Acquire A | No | No | 0 | 56 | 0.00 | 56 |
